ArticleOncoTargets and therapy2017

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

Ben C Creelan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.